Scientific breakthroughs have changed the way cancer is treated, and many new cancer drugs are administered orally, but health care coverage policies have not kept up with these innovations. Many health insurance plans require that cancer patients pay higher out-of-pocket costs for oral cancer medicines than those that are injected or administered intravenously.
As a member of the Coalition to Improve Access to Cancer Care (CIACC), we are advocating for policies that ensure that colorectal cancer patients have access to the best treatments, regardless of how those treatments are administered.
